{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:00:12Z","timestamp":1793977212039,"version":"4.8.0"},"reference-count":217,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1038\/s41584-022-00880-7","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:03:32Z","timestamp":1671620612000},"page":"111-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":165,"title":["Vascular Beh\u00e7et syndrome: from pathogenesis to treatment"],"prefix":"10.1038","volume":"19","author":[{"given":"Alessandra","family":"Bettiol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Alibaz-Oner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2598-5806","authenticated-orcid":false,"given":"Haner","family":"Direskeneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulen","family":"Hatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emire","family":"Seyahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9575-8321","authenticated-orcid":false,"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"880_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","volume":"43","author":"H Yazici","year":"2012","unstructured":"Yazici, H., Ugurlu, S. & Seyahi, E. Beh\u00e7et syndrome: is it one condition? Clin. Rev. Allergy Immunol. 43, 275\u2013280 (2012).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"880_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11739-019-02046-y","volume":"14","author":"E Seyahi","year":"2019","unstructured":"Seyahi, E. Phenotypes in Beh\u00e7et\u2019s syndrome. Intern. Emerg. Med. 14, 677\u2013689 (2019).","journal-title":"Intern. Emerg. Med."},{"key":"880_CR3","doi-asserted-by":"publisher","first-page":"iii101","DOI":"10.1093\/rheumatology\/kez626","volume":"59","author":"A Bettiol","year":"2020","unstructured":"Bettiol, A., Prisco, D. & Emmi, G. Beh\u00e7et: the syndrome. Rheumatology 59, iii101\u2013iii107 (2020).","journal-title":"Rheumatology"},{"key":"880_CR4","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","volume":"53","author":"K Tascilar","year":"2014","unstructured":"Tascilar, K. et al. Vascular involvement in Beh\u00e7et\u2019s syndrome: a retrospective analysis of associations and the time course. Rheumatology 53, 2018\u20132022 (2014).","journal-title":"Rheumatology"},{"key":"880_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00296-010-1363-z","volume":"31","author":"JK Alkaabi","year":"2011","unstructured":"Alkaabi, J. K. & Pathare, A. Pattern and outcome of vascular involvement of Omani patients with Behcet\u2019s disease. Rheumatol. Int. 31, 731\u2013735 (2011).","journal-title":"Rheumatol. Int."},{"key":"880_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","volume":"82","author":"E Kural-Seyahi","year":"2003","unstructured":"Kural-Seyahi, E. et al. The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 82, 60\u201376 (2003).","journal-title":"Medicine"},{"key":"880_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","volume":"13","author":"F Davatchi","year":"2017","unstructured":"Davatchi, F. et al. Behcet\u2019s disease: epidemiology, clinical manifestations, and diagnosis. Expert. Rev. Clin. Immunol. 13, 57\u201365 (2017).","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"880_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/rheumatology\/40.6.652","volume":"40","author":"PR Ames","year":"2001","unstructured":"Ames, P. R., Steuer, A., Pap, A. & Denman, A. M. Thrombosis in Beh\u00e7et\u2019s disease: a retrospective survey from a single UK centre. Rheumatology 40, 652\u2013655 (2001).","journal-title":"Rheumatology"},{"key":"880_CR9","first-page":"63","volume":"36","author":"B Kara Kivanc","year":"2018","unstructured":"Kara Kivanc, B. et al. Why are male patients with Beh\u00e7et\u2019s disease prone to thrombosis? A rotational thromboelastographic analysis. Clin. Exp. Rheumatol. 36, 63\u201367 (2018).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR10","doi-asserted-by":"publisher","first-page":"h2039","DOI":"10.1136\/bmj.h2039","volume":"350","author":"H Nasr","year":"2015","unstructured":"Nasr, H. & Scriven, J. M. Superficial thrombophlebitis (superficial venous thrombosis). Br. Med. J. 350, h2039 (2015).","journal-title":"Br. Med. J."},{"key":"880_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12959-015-0039-z","volume":"13","author":"SA Sarr","year":"2015","unstructured":"Sarr, S. A. et al. Superior vena cava syndrome revealing a Beh\u00e7et\u2019s disease. Thromb. J. 13, 7 (2015).","journal-title":"Thromb. J."},{"key":"880_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11239-022-02637-1","volume":"54","author":"N Toledo-Samaniego","year":"2022","unstructured":"Toledo-Samaniego, N. et al. Arterial and venous involvement in Beh\u00e7et\u2019s syndrome: a narrative review. J. Thromb. Thrombolysis 54, 162\u2013171 (2022).","journal-title":"J. Thromb. Thrombolysis"},{"key":"880_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s11739-018-1991-y","volume":"14","author":"G Emmi","year":"2019","unstructured":"Emmi, G. et al. Vascular Beh\u00e7et\u2019s syndrome: an update. Intern. Emerg. Med. 14, 645\u2013652 (2019).","journal-title":"Intern. Emerg. Med."},{"key":"880_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/cei.13243","volume":"195","author":"M Becatti","year":"2019","unstructured":"Becatti, M. et al. Beh\u00e7et\u2019s syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects. Clin. Exp. Immunol. 195, 322\u2013333 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"880_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-15","volume":"6","author":"U Khalid","year":"2011","unstructured":"Khalid, U. & Saleem, T. Hughes-Stovin syndrome. Orphanet J. Rare Dis. 6, 15 (2011).","journal-title":"Orphanet J. Rare Dis."},{"key":"880_CR16","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1378\/chest.127.6.2243","volume":"127","author":"O Uzun","year":"2005","unstructured":"Uzun, O., Akpolat, T. & Erkan, L. Pulmonary vasculitis in Beh\u00e7et disease: a cumulative analysis. Chest 127, 2243\u20132253 (2005).","journal-title":"Chest"},{"key":"880_CR17","doi-asserted-by":"publisher","first-page":"713052","DOI":"10.3389\/fmed.2021.713052","volume":"8","author":"I Mattioli","year":"2021","unstructured":"Mattioli, I., Bettiol, A., Saruhan-Direskeneli, G., Direskeneli, H. & Emmi, G. Pathogenesis of Beh\u00e7et\u2019s syndrome: genetic, environmental and immunological factors. Front. Med. 8, 713052 (2021).","journal-title":"Front. Med."},{"key":"880_CR18","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.3389\/fimmu.2019.02830","volume":"10","author":"A Bettiol","year":"2019","unstructured":"Bettiol, A. et al. Treating the different phenotypes of Beh\u00e7et\u2019s syndrome. Front. Immunol. 10, 2830 (2019).","journal-title":"Front. Immunol."},{"key":"880_CR19","doi-asserted-by":"crossref","unstructured":"Demirkesen, C., Oz, B. & Goksel, S. in Beh\u00e7et\u2019s syndrome 171\u2013189 (Springer, 2020).","DOI":"10.1007\/978-3-030-24131-5_12"},{"key":"880_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12959-015-0047-z","volume":"13","author":"G Emmi","year":"2015","unstructured":"Emmi, G. et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thromb. J. 13, 15 (2015).","journal-title":"Thromb. J."},{"key":"880_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3389\/fimmu.2019.01085","volume":"10","author":"G Emmi","year":"2019","unstructured":"Emmi, G. et al. Beh\u00e7et\u2019s syndrome as a model of thrombo-inflammation: the role of neutrophils. Front. Immunol. 10, 1085 (2019).","journal-title":"Front. Immunol."},{"key":"880_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nm0810-851","volume":"16","author":"W Ruf","year":"2010","unstructured":"Ruf, W. & Ruggeri, Z. M. Neutrophils release brakes of coagulation. Nat. Med. 16, 851\u2013852 (2010).","journal-title":"Nat. Med."},{"key":"880_CR23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","volume":"110","author":"O Soehnlein","year":"2012","unstructured":"Soehnlein, O. Multiple roles for neutrophils in atherosclerosis. Circ. Res. 110, 875\u2013888 (2012).","journal-title":"Circ. Res."},{"key":"880_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1365-2559.2000.00859.x","volume":"36","author":"M Kobayashi","year":"2000","unstructured":"Kobayashi, M. et al. Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Beh\u00e7et disease. Histopathology 36, 362\u2013371 (2000).","journal-title":"Histopathology"},{"key":"880_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/ard.55.2.128","volume":"55","author":"S Sahin","year":"1996","unstructured":"Sahin, S., Akoglu, T., Direskeneli, H., Sen, L. S. & Lawrence, R. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Beh\u00e7et\u2019s disease. Ann. Rheum. Dis. 55, 128\u2013133 (1996).","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR26","first-page":"S19","volume":"19","author":"E Eksioglu-Demiralp","year":"2001","unstructured":"Eksioglu-Demiralp, E. et al. Neutrophil activation in Beh\u00e7et\u2019s disease. Clin. Exp. Rheumatol. 19, S19\u2013S24 (2001).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/gene.2016.28","volume":"17","author":"S Yavuz","year":"2016","unstructured":"Yavuz, S. et al. Dual effects of testosterone in Behcet\u2019s disease: implications for a role in disease pathogenesis. Genes. Immun. 17, 335\u2013341 (2016).","journal-title":"Genes. Immun."},{"key":"880_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-4632.2009.03905.x","volume":"48","author":"SP Durmazlar","year":"2009","unstructured":"Durmazlar, S. P. et al. Significance of serum interleukin-8 levels in patients with Behcet\u2019s disease: high levels may indicate vascular involvement. Int. J. Dermatol. 48, 259\u2013264 (2009).","journal-title":"Int. J. Dermatol."},{"key":"880_CR29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/CIRCULATIONAHA.115.017738","volume":"133","author":"M Becatti","year":"2016","unstructured":"Becatti, M. et al. Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Beh\u00e7et disease. Circulation 133, 302\u2013311 (2016). This study investigated the pathogenesis of thrombo-inflammation in vascular Beh\u00e7et syndrome, and demonstrated how oxidative stress can induce pro-thrombotic modifications of fibrinogen, a key molecule involved in the coagulation pathway.","journal-title":"Circulation"},{"key":"880_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0923-1811(97)00613-0","volume":"16","author":"A Orem","year":"1997","unstructured":"Orem, A. et al. Relationship between lipid peroxidation and disease activity in patients with Beh\u00e7et\u2019s disease. J. Dermatol. Sci. 16, 11\u201316 (1997).","journal-title":"J. Dermatol. Sci."},{"key":"880_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000018122","volume":"198","author":"A Orem","year":"1999","unstructured":"Orem, A., Cimsit, G., Deger, O., Vanizor, B. & Karahan, S. C. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Beh\u00e7et\u2019s disease. Dermatology 198, 243\u2013246 (1999).","journal-title":"Dermatology"},{"key":"880_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0009-9120(02)00290-4","volume":"35","author":"A Orem","year":"2002","unstructured":"Orem, A. et al. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Beh\u00e7et\u2019s disease. Clin. Biochem. 35, 217\u2013224 (2002).","journal-title":"Clin. Biochem."},{"key":"880_CR33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3390\/biom5020702","volume":"5","author":"W Stoiber","year":"2015","unstructured":"Stoiber, W., Obermayer, A., Steinbacher, P. & Krautgartner, W. D. The role of reactive oxygen species (ROS) in the formation of extracellular traps (ETs) in humans. Biomolecules 5, 702\u2013723 (2015).","journal-title":"Biomolecules"},{"key":"880_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fimmu.2017.00081","volume":"8","author":"V Delgado-Rizo","year":"2017","unstructured":"Delgado-Rizo, V. et al. Neutrophil extracellular traps and its implications in inflammation: an overview. Front. Immunol. 8, 81 (2017).","journal-title":"Front. Immunol."},{"key":"880_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-21947","author":"J Chen","year":"2020","unstructured":"Chen, J., Liu, T., He, J. & Liu, Y. Correspondence on \u2018Critical role of neutrophil extracellular traps (NETs) in patients with Behcet\u2019s disease\u2019. Ann. Rheum. Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2020-21947 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jdermsci.2018.08.010","volume":"92","author":"R Safi","year":"2018","unstructured":"Safi, R. et al. Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Beh\u00e7et\u2019s disease. J. Dermatol. Sci. 92, 143\u2013150 (2018).","journal-title":"J. Dermatol. Sci."},{"key":"880_CR37","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1136\/annrheumdis-2018-214335","volume":"78","author":"A Le Joncour","year":"2019","unstructured":"Le Joncour, A. et al. Critical role of neutrophil extracellular traps (NETs) in patients with Behcet\u2019s disease. Ann. Rheum. Dis. 78, 1274\u20131282 (2019). This study showed the role of NETs as a potential mechanism of neutrophil-induced thrombo-inflammation.","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR38","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/cei.13664","volume":"206","author":"A Bettiol","year":"2021","unstructured":"Bettiol, A. et al. Neutrophil-mediated mechanisms of damage and in-vitro protective effect of colchicine in non-vascular Beh\u00e7et\u2019s syndrome. Clin. Exp. Immunol. 206, 410\u2013421 (2021).","journal-title":"Clin. Exp. Immunol."},{"key":"880_CR39","doi-asserted-by":"publisher","first-page":"590622","DOI":"10.3389\/fimmu.2020.590622","volume":"11","author":"L Li","year":"2020","unstructured":"Li, L. et al. Neutrophil extracellular traps promote aberrant macrophages activation in Beh\u00e7et\u2019s disease. Front. Immunol. 11, 590622 (2020).","journal-title":"Front. Immunol."},{"key":"880_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaut.2015.08.018","volume":"67","author":"D Nakazawa","year":"2016","unstructured":"Nakazawa, D. et al. The responses of macrophages in interaction with neutrophils that undergo NETosis. J. Autoimmun. 67, 19\u201328 (2016).","journal-title":"J. Autoimmun."},{"key":"880_CR41","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1161\/ATVBAHA.118.311150","volume":"38","author":"EJ Folco","year":"2018","unstructured":"Folco, E. J. et al. Neutrophil extracellular traps induce endothelial cell activation and tissue factor production through interleukin-1\u0251 and cathepsin G. Arterioscler. Thromb. Vasc. Biol. 38, 1901\u20131912 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"880_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","volume":"14","author":"C Consolandi","year":"2015","unstructured":"Consolandi, C. et al. Beh\u00e7et\u2019s syndrome patients exhibit specific microbiome signature. Autoimmun. Rev. 14, 269\u2013276 (2015). This study demonstrated how Beh\u00e7et\u2019s syndrome is characterized by a specific microbiome signature and microbiota dysbiosis.","journal-title":"Autoimmun. Rev."},{"key":"880_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrmicro.2017.149","volume":"16","author":"JM Brown","year":"2018","unstructured":"Brown, J. M. & Hazen, S. L. Microbial modulation of cardiovascular disease. Nat. Rev. Microbiol. 16, 171\u2013181 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"880_CR44","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/CIRCRESAHA.120.317789","volume":"128","author":"G Emmi","year":"2021","unstructured":"Emmi, G. et al. Butyrate-rich diets improve redox status and fibrin lysis in Beh\u00e7et\u2019s syndrome. Circ. Res. 128, 278\u2013280 (2021). This pilot study investigated for the first time the effects of tailored nutritional interventions to reduce redox status and the consequent pro-thrombotic milieu in patients with Beh\u00e7et syndrome.","journal-title":"Circ. Res."},{"key":"880_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04444-6","volume":"21","author":"G Pagliai","year":"2020","unstructured":"Pagliai, G. et al. Modulation of gut microbiota through nutritional interventions in Beh\u00e7et\u2019s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial. Trials 21, 511 (2020).","journal-title":"Trials"},{"key":"880_CR46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/1346-8138.16391","volume":"49","author":"T Kawakami","year":"2022","unstructured":"Kawakami, T. et al. Presence of neutrophil extracellular traps in superficial venous thrombosis of Beh\u00e7et\u2019s disease. J. Dermatol. 49, 741\u2013745 (2022).","journal-title":"J. Dermatol."},{"key":"880_CR47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/15569527.2011.554480","volume":"30","author":"E Onur","year":"2011","unstructured":"Onur, E. et al. Oxidative stress impairs endothelial nitric oxide levels in Beh\u00e7ets\u2019 disease. Cutan. Ocul. Toxicol. 30, 217\u2013220 (2011).","journal-title":"Cutan. Ocul. Toxicol."},{"key":"880_CR48","first-page":"449","volume":"36","author":"M Sahin","year":"2006","unstructured":"Sahin, M. et al. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet\u2019s disease. Ann. Clin. Lab. Sci. 36, 449\u2013454 (2006).","journal-title":"Ann. Clin. Lab. Sci."},{"key":"880_CR49","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3109\/03009749509095184","volume":"24","author":"K Ozoran","year":"1995","unstructured":"Ozoran, K., Dugun, N., Gurler, A., Tutkak, H. & Tokgoz, G. Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Beh\u00e7et\u2019s disease. Scand. J. Rheumatol. 24, 376\u2013382 (1995).","journal-title":"Scand. J. Rheumatol."},{"key":"880_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1600-0609.1996.tb00499.x","volume":"57","author":"IC Haznedaroglu","year":"1996","unstructured":"Haznedaroglu, I. C., Ozcebe, O., Celik, I., Dundar, S. V. & Kirazhi, S. Haemostatic markers of procoagulant imbalance in Beh\u00e7et\u2019s disease. Eur. J. Haematol. 57, 107\u2013108 (1996).","journal-title":"Eur. J. Haematol."},{"key":"880_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1055\/s-0035-1556727","volume":"41","author":"NV Butta","year":"2015","unstructured":"Butta, N. V., Fernandez-Bello, I., Lopez-Longo, F. J. & Jimenez-Yuste, V. Endothelial dysfunction and altered coagulation as mediators of thromboembolism in Beh\u00e7et disease. Semin. Thromb. Hemost. 41, 621\u2013628 (2015).","journal-title":"Semin. Thromb. Hemost."},{"key":"880_CR52","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.3389\/fimmu.2019.02877","volume":"10","author":"G Emmi","year":"2019","unstructured":"Emmi, G. et al. Stem-cell-derived circulating progenitors dysfunction in Beh\u00e7et\u2019s syndrome patients correlates with oxidative stress. Front. Immunol. 10, 2877 (2019).","journal-title":"Front. Immunol."},{"key":"880_CR53","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1006\/clim.1999.4687","volume":"91","author":"G Triolo","year":"1999","unstructured":"Triolo, G. et al. Enhancement of endothelial cell E-selectin expression by sera from patients with active Beh\u00e7et\u2019s disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels. Clin. Immunol. 91, 330\u2013337 (1999).","journal-title":"Clin. Immunol."},{"key":"880_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10067-004-0982-8","volume":"24","author":"RA Sari","year":"2005","unstructured":"Sari, R. A., Kiziltunc, A., Tays\u2019y, S., Akdem\u2019yr, S. & Gundogdu, M. Levels of soluble E-selectin in patients with active Beh\u00e7et\u2019s disease. Clin. Rheumatol. 24, 55\u201359 (2005).","journal-title":"Clin. Rheumatol."},{"key":"880_CR55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1155\/MI.2005.237","volume":"2005","author":"Y Turkoz","year":"2005","unstructured":"Turkoz, Y. et al. Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Beh\u00e7et\u2019s syndrome. Mediators Inflamm. 2005, 237\u2013241 (2005).","journal-title":"Mediators Inflamm."},{"key":"880_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000112635","volume":"36","author":"M Martinez","year":"2007","unstructured":"Martinez, M. et al. Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Beh\u00e7et\u2019s disease: are they related to thrombotic events? Pathophysiol. Haemost. Thromb. 36, 18\u201322 (2007).","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"880_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1163\/156855902320387952","volume":"32","author":"G Polat","year":"2002","unstructured":"Polat, G. et al. Association of the platelet glycoprotein Ia C807T\/G873A gene polymorphism and thrombosis in Beh\u00e7et patients. Haematologia 32, 121\u2013128 (2002).","journal-title":"Haematologia"},{"key":"880_CR58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1346-8138.1984.tb01452.x","volume":"11","author":"S Haim","year":"1984","unstructured":"Haim, S. et al. Platelet function in Beh\u00e7et\u2019s disease. J. Dermatol. 11, 117\u2013120 (1984).","journal-title":"J. Dermatol."},{"key":"880_CR59","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/1076029606293430","volume":"12","author":"S Akar","year":"2006","unstructured":"Akar, S. et al. Circulated activated platelets and increased platelet reactivity in patients with Beh\u00e7et\u2019s disease. Clin. Appl. Thromb. Hemost. 12, 451\u2013457 (2006).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"880_CR60","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2362.1988.tb01032.x","volume":"18","author":"AP Wilson","year":"1988","unstructured":"Wilson, A. P., Efthimiou, J. & Betteridge, D. J. Decreased prostacyclin sensitivity of platelets in patients with Beh\u00e7et\u2019s syndrome. Eur. J. Clin. Invest. 18, 410\u2013414 (1988).","journal-title":"Eur. J. Clin. Invest."},{"key":"880_CR61","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1055\/s-0035-1549850","volume":"41","author":"E Niccolai","year":"2015","unstructured":"Niccolai, E. et al. Microparticles: bridging the gap between autoimmunity and thrombosis. Semin. Thromb. Hemost. 41, 413\u2013422 (2015).","journal-title":"Semin. Thromb. Hemost."},{"key":"880_CR62","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1093\/rheumatology\/ker177","volume":"50","author":"M Macey","year":"2011","unstructured":"Macey, M. et al. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Beh\u00e7et\u2019s disease. Rheumatol 50, 1849\u20131859 (2011).","journal-title":"Rheumatol"},{"key":"880_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/srep38104","volume":"6","author":"E Khan","year":"2016","unstructured":"Khan, E. et al. A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Beh\u00e7et\u2019s Syndrome. Sci. Rep. 6, 38104 (2016).","journal-title":"Sci. Rep."},{"key":"880_CR64","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/annrheumdis-2021-220859","volume":"81","author":"G Emmi","year":"2022","unstructured":"Emmi, G. et al. A unique circulating miRNA profile highlights thrombo-inflammation in Beh\u00e7et\u2019s syndrome. Ann. Rheum. Dis. 81, 386\u2013397 (2022). This study investigated for the first time the role of circulating miRNA in thrombo-inflammation in Beh\u00e7et syndrome.","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR65","doi-asserted-by":"publisher","first-page":"107435","DOI":"10.1016\/j.dib.2021.107435","volume":"38","author":"G Bagni","year":"2021","unstructured":"Bagni, G. et al. Circulating miRNome profiling data in Beh\u00e7et\u2019s syndrome. Data Brief. 38, 107435 (2021).","journal-title":"Data Brief."},{"key":"880_CR66","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jbspin.2010.02.022","volume":"77","author":"P Caramaschi","year":"2010","unstructured":"Caramaschi, P. et al. A study on thrombophilic factors in Italian Behcet\u2019s patients. Jt. Bone Spine 77, 330\u2013334 (2010).","journal-title":"Jt. Bone Spine"},{"key":"880_CR67","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1046\/j.1365-2796.1996.396853000.x","volume":"240","author":"IC Haznedaroglu","year":"1996","unstructured":"Haznedaroglu, I. C. et al. Impaired haemostatic kinetics and endothelial function in Beh\u00e7et\u2019s disease. J. Intern. Med. 240, 181\u2013187 (1996).","journal-title":"J. Intern. Med."},{"key":"880_CR68","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/ard.48.7.590","volume":"48","author":"R Aitchison","year":"1989","unstructured":"Aitchison, R., Chu, P., Cater, D. R., Harris, R. J. & Powell, R. J. Defective fibrinolysis in Beh\u00e7et\u2019s syndrome: significance and possible mechanisms. Ann. Rheum. Dis. 48, 590\u2013593 (1989).","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR69","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1055\/s-0038-1646409","volume":"66","author":"KK Hampton","year":"1991","unstructured":"Hampton, K. K., Chamberlain, M. A., Menon, D. K. & Davies, J. A. Coagulation and fibrinolytic activity in Beh\u00e7et\u2019s disease. Thromb. Haemost. 66, 292\u2013294 (1991).","journal-title":"Thromb. Haemost."},{"key":"880_CR70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0049-3848(02)00085-3","volume":"106","author":"YJ Lee","year":"2002","unstructured":"Lee, Y. J. et al. Coagulation parameters and plasma total homocysteine levels in Behcet\u2019s disease. Thromb. Res. 106, 19\u201324 (2002).","journal-title":"Thromb. Res."},{"key":"880_CR71","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ajh.20317","volume":"79","author":"E Beyan","year":"2005","unstructured":"Beyan, E., Sadikoglu, B., Ertugrul, E. & Beyan, C. Von Willebrand factor antigen levels in Beh\u00e7et disease. Am. J. Hematol. 79, 70\u201372 (2005).","journal-title":"Am. J. Hematol."},{"key":"880_CR72","first-page":"67","volume":"16","author":"S Esmat","year":"2006","unstructured":"Esmat, S. et al. Lipoprotein (a) and nitrites in Behcet\u2019s disease: relationship with disease activity and vascular complications. Eur. J. Dermatol. 16, 67\u201371 (2006).","journal-title":"Eur. J. Dermatol."},{"key":"880_CR73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/112067210101100112","volume":"11","author":"O Gurbuz","year":"2001","unstructured":"Gurbuz, O., Ozdemir, Y., Cosar, C. B. & Kural, G. Lipoprotein (a) in Beh\u00e7et\u2019s disease as an indicator of disease activity and in thrombotic complications. Eur. J. Ophthalmol. 11, 62\u201365 (2001).","journal-title":"Eur. J. Ophthalmol."},{"key":"880_CR74","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1136\/ard.2003.014241","volume":"63","author":"M Leiba","year":"2004","unstructured":"Leiba, M. et al. Thrombophilic factors are not the leading cause of thrombosis in Beh\u00e7et\u2019s disease. Ann. Rheum. Dis. 63, 1445\u20131449 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR75","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1136\/ard.2005.049551","volume":"65","author":"JM Ricart","year":"2006","unstructured":"Ricart, J. M., Vaya, A., Santaolaria, M., Espana, F. & Aznar, J. Dyslipidaemia in Beh\u00e7et\u2019s disease as a thrombotic risk factor. Ann. Rheum. Dis. 65, 1248\u20131249 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR76","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1046\/j.1365-4362.1998.00114.x","volume":"37","author":"N Lenk","year":"1998","unstructured":"Lenk, N., Ozet, G., Alli, N., Coban, O. & Erbasi, S. Protein C and protein S activities in Beh\u00e7et\u2019s disease as risk factors of thrombosis. Int. J. Dermatol. 37, 124\u2013125 (1998).","journal-title":"Int. J. Dermatol."},{"key":"880_CR77","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/030006059802600405","volume":"26","author":"M Nalcaci","year":"1998","unstructured":"Nalcaci, M. & Pekcelen, Y. Antithrombin III, protein C and protein S plasma levels in patients with Beh\u00e7et\u2019s disease. J. Int. Med. Res. 26, 206\u2013208 (1998).","journal-title":"J. Int. Med. Res."},{"key":"880_CR78","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9343(01)01048-8","volume":"112","author":"G Espinosa","year":"2002","unstructured":"Espinosa, G. et al. Vascular involvement in Beh\u00e7et\u2019s disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am. J. Med. 112, 37\u201343 (2002).","journal-title":"Am. J. Med."},{"key":"880_CR79","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0049-3848(97)00063-7","volume":"86","author":"S Guermazi","year":"1997","unstructured":"Guermazi, S., Hamza, M. & Dellagi, K. Protein S deficiency and antibodies to protein S in patients with Beh\u00e7et\u2019s disease. Thromb. Res. 86, 197\u2013204 (1997).","journal-title":"Thromb. Res."},{"key":"880_CR80","first-page":"e190","volume":"14","author":"JK Alkaabi","year":"2014","unstructured":"Alkaabi, J. K., Gravell, D., Al-Haddabi, H. & Pathare, A. Haemostatic parameters in patients with Beh\u00e7et\u2019s disease. Sultan Qaboos Univ. Med. J. 14, e190\u2013e196 (2014).","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"880_CR81","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1053\/ejvs.2000.1091","volume":"19","author":"S Demirer","year":"2000","unstructured":"Demirer, S. et al. Haemostasis in patients with Beh\u00e7et\u2019s disease. Eur. J. Vasc. Endovasc. Surg. 19, 570\u2013574 (2000).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"880_CR82","first-page":"5588","volume":"8","author":"EM Conway","year":"1988","unstructured":"Conway, E. M. & Rosenberg, R. D. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell. Biol. 8, 5588\u20135592 (1988).","journal-title":"Mol. Cell. Biol."},{"key":"880_CR83","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1182\/blood.V77.3.542.542","volume":"77","author":"SR Lentz","year":"1991","unstructured":"Lentz, S. R., Tsiang, M. & Sadler, J. E. Regulation of thrombomodulin by tumor necrosis factor-\u0251: comparison of transcriptional and posttranscriptional mechanisms. Blood 77, 542\u2013550 (1991).","journal-title":"Blood"},{"key":"880_CR84","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1365-2141.2004.05072.x","volume":"126","author":"S Navarro","year":"2004","unstructured":"Navarro, S. et al. Activated protein C levels in Beh\u00e7et\u2019s disease and risk of venous thrombosis. Br. J. Haematol. 126, 550\u2013556 (2004).","journal-title":"Br. J. Haematol."},{"key":"880_CR85","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s002960050043","volume":"17","author":"A Ko\u015far","year":"1998","unstructured":"Ko\u015far, A., Haznedaroglu, I. C., Buyukasik, Y., Kirazli, S. & Dundar, S. V. Activated protein C resistance in Beh\u00e7et\u2019s disease. Rheumatol. Int. 17, 249\u2013250 (1998).","journal-title":"Rheumatol. Int."},{"key":"880_CR86","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/rheumatology\/35.11.1178","volume":"35","author":"A G\u00fcl","year":"1996","unstructured":"G\u00fcl, A. et al. Coagulation factor V gene mutation increases the risk of venous thrombosis in Beh\u00e7et\u2019s disease. Br. J. Rheumatol. 35, 1178\u20131180 (1996).","journal-title":"Br. J. Rheumatol."},{"key":"880_CR87","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0002-9394(99)00184-1","volume":"128","author":"DH Verity","year":"1999","unstructured":"Verity, D. H. et al. Factor V Leiden mutation is associated with ocular involvement in Beh\u00e7et disease. Am. J. Ophthalmol. 128, 352\u2013356 (1999).","journal-title":"Am. J. Ophthalmol."},{"key":"880_CR88","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1034\/j.1600-0420.2003.00068.x","volume":"81","author":"F Batioglu","year":"2003","unstructured":"Batioglu, F., Atmaca, L. S., Karabulut, H. G. & Beyza Sayin, D. Factor V Leiden and prothrombin gene G20210A mutations in ocular Beh\u00e7et disease. Acta Ophthalmol. Scand. 81, 283\u2013285 (2003).","journal-title":"Acta Ophthalmol. Scand."},{"key":"880_CR89","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1089\/gtmb.2011.0096","volume":"16","author":"E Dagan","year":"2012","unstructured":"Dagan, E. et al. Vascular Behcet and mutations in thrombogenic genes: methylene tetrahydrofolate reductase, factor V, and prothrombin. Genet. Test. Mol. Biomark. 16, 30\u201335 (2012).","journal-title":"Genet. Test. Mol. Biomark."},{"key":"880_CR90","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/ajh.1186","volume":"68","author":"M Akarsu","year":"2001","unstructured":"Akarsu, M. et al. Increased levels of tissue factor pathway inhibitor may reflect disease activity and play a role in thrombotic tendency in Beh\u00e7et\u2019s disease. Am. J. Hematol. 68, 225\u2013230 (2001).","journal-title":"Am. J. Hematol."},{"key":"880_CR91","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/rheumatology\/38.12.1298","volume":"38","author":"A Gul","year":"1999","unstructured":"Gul, A., Aslantas, A. B., Tekinay, T., Konice, M. & Ozcelik, T. Procoagulant mutations and venous thrombosis in Beh\u00e7et\u2019s disease. Rheumatology 38, 1298\u20131299 (1999).","journal-title":"Rheumatology"},{"key":"880_CR92","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1160\/TH05-10-0659","volume":"95","author":"JM Ricart","year":"2006","unstructured":"Ricart, J. M. et al. Thrombophilic risk factors and homocysteine levels in Beh\u00e7et\u2019s disease in eastern Spain and their association with thrombotic events. Thromb. Haemost. 95, 618\u2013624 (2006).","journal-title":"Thromb. Haemost."},{"key":"880_CR93","first-page":"S67","volume":"32","author":"JC Mejia","year":"2014","unstructured":"Mejia, J. C., Espinosa, G., Tassies, D., Reverter, J. C. & Cervera, R. Endogenous thrombin potential in Beh\u00e7et\u2019s disease: relationship with thrombosis and anticoagulant therapy. Clin. Exp. Rheumatol. 32, S67\u2013S71 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR94","first-page":"2849","volume":"27","author":"PB Toydemir","year":"2000","unstructured":"Toydemir, P. B. et al. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutations on deep venous thrombogenesis in Beh\u00e7et\u2019s disease. J. Rheumatol. 27, 2849\u20132854 (2000).","journal-title":"J. Rheumatol."},{"key":"880_CR95","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.thromres.2020.10.010","volume":"198","author":"Z Sayar","year":"2021","unstructured":"Sayar, Z., Moll, R., Isenberg, D. & Cohen, H. Thrombotic antiphospholipid syndrome: a practical guide to diagnosis and management. Thromb. Res. 198, 213\u2013221 (2021).","journal-title":"Thromb. Res."},{"key":"880_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227836","volume":"15","author":"MA Islam","year":"2020","unstructured":"Islam, M. A. et al. Prevalence of antiphospholipid antibodies in Beh\u00e7et\u2019s disease: a systematic review and meta-analysis. PLoS One 15, e0227836 (2020).","journal-title":"PLoS One"},{"key":"880_CR97","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/rheumatology\/40.2.192","volume":"40","author":"S Tokay","year":"2001","unstructured":"Tokay, S., Direskeneli, H., Yurdakul, S. & Akoglu, T. Anticardiolipin antibodies in Beh\u00e7et\u2019s disease: a reassessment. Rheumatology 40, 192\u2013195 (2001).","journal-title":"Rheumatology"},{"key":"880_CR98","first-page":"2404","volume":"26","author":"R Mader","year":"1999","unstructured":"Mader, R., Ziv, M., Adawi, M., Mader, R. & Lavi, I. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Beh\u00e7et\u2019s disease. J. Rheumatol. 26, 2404\u20132408 (1999).","journal-title":"J. Rheumatol."},{"key":"880_CR99","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/ATVBAHA.110.207068","volume":"30","author":"M La Regina","year":"2010","unstructured":"La Regina, M., Orlandini, F., Prisco, D. & Dentali, F. Homocysteine in vascular Beh\u00e7et disease: a meta-analysis. Arterioscler. Thromb. Vasc. Biol. 30, 2067\u20132074 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"880_CR100","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.thromres.2003.08.022","volume":"111","author":"BO Choi","year":"2003","unstructured":"Choi, B. O. et al. Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. Thromb. Res. 111, 39\u201344 (2003).","journal-title":"Thromb. Res."},{"key":"880_CR101","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2796.2000.00711.x","volume":"248","author":"A Altinba\u015f","year":"2000","unstructured":"Altinba\u015f, A. et al. Hyperhomocysteinaemia and activated protein C resistance in Beh\u00e7et\u2019s disease. J. Intern. Med. 248, 267\u2013268 (2000).","journal-title":"J. Intern. Med."},{"key":"880_CR102","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1515\/CCLM.2006.191","volume":"44","author":"AG Mungan","year":"2006","unstructured":"Mungan, A. G., Can, M., A\u00e7ikg\u00f6z, S., E\u015ft\u00fcrk, E. & Altinyazar, C. Lipid peroxidation and homocysteine levels in Beh\u00e7et\u2019s disease. Clin. Chem. Lab. Med. 44, 1115\u20131118 (2006).","journal-title":"Clin. Chem. Lab. Med."},{"key":"880_CR103","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1365-2133.2005.06543.x","volume":"153","author":"S Buldanlioglu","year":"2005","unstructured":"Buldanlioglu, S. et al. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Beh\u00e7et\u2019s disease. Br. J. Dermatol. 153, 526\u2013530 (2005).","journal-title":"Br. J. Dermatol."},{"key":"880_CR104","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s00296-003-0301-8","volume":"23","author":"A Canataroglu","year":"2003","unstructured":"Canataroglu, A. et al. Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Beh\u00e7et\u2019s disease. Rheumatol. Int. 23, 236\u2013240 (2003).","journal-title":"Rheumatol. Int."},{"key":"880_CR105","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12016-007-8064-8","volume":"35","author":"M Melikoglu","year":"2008","unstructured":"Melikoglu, M., Kural-Seyahi, E., Tascilar, K. & Yazici, H. The unique features of vasculitis in Beh\u00e7et\u2019s syndrome. Clin. Rev. Allergy Immunol. 35, 40\u201346 (2008).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"880_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1061-1","volume":"14","author":"Y Chen","year":"2019","unstructured":"Chen, Y., Cai, J. F., Lin, C. H. & Guan, J. L. Demography of vascular Behcet\u2019s disease with different gender and age: an investigation with 166 Chinese patients. Orphanet J. Rare Dis. 14, 88 (2019).","journal-title":"Orphanet J. Rare Dis."},{"key":"880_CR107","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001899","volume":"94","author":"E Seyahi","year":"2015","unstructured":"Seyahi, E. et al. Clinical and ultrasonographic evaluation of lower-extremity vein thrombosis in Behcet syndrome: an observational study. Medicine 94, e1899 (2015).","journal-title":"Medicine"},{"key":"880_CR108","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jvs.2011.07.049","volume":"55","author":"H Tuzun","year":"2012","unstructured":"Tuzun, H. et al. Management and prognosis of nonpulmonary large arterial disease in patients with Beh\u00e7et disease. J. Vasc. Surg. 55, 157\u2013163 (2012).","journal-title":"J. Vasc. Surg."},{"key":"880_CR109","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/rheumatology\/kez352","volume":"59","author":"Y Ozguler","year":"2020","unstructured":"Ozguler, Y. et al. Clinical course of acute deep vein thrombosis of the legs in Beh\u00e7et\u2019s syndrome. Rheumatology 59, 799\u2013806 (2020).","journal-title":"Rheumatology"},{"key":"880_CR110","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/art.34450","volume":"64","author":"AC Desbois","year":"2012","unstructured":"Desbois, A. C. et al. Immunosuppressants reduce venous thrombosis relapse in Beh\u00e7et\u2019s disease. Arthritis Rheum. 64, 2753\u20132760 (2012).","journal-title":"Arthritis Rheum."},{"key":"880_CR111","first-page":"64","volume":"31","author":"E Seyahi","year":"2013","unstructured":"Seyahi, E., Karaaslan, H., Ugurlu, S. & Yazici, H. Fever in Beh\u00e7et\u2019s syndrome. Clin. Exp. Rheumatol. 31, 64\u201367 (2013).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR112","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","volume":"14","author":"H Yazici","year":"2018","unstructured":"Yazici, H., Seyahi, E., Hatemi, G. & Yazici, Y. Beh\u00e7et syndrome: a contemporary view. Nat. Rev. Rheumatol. 14, 107\u2013119 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"880_CR113","first-page":"S54","volume":"33","author":"S Celik","year":"2015","unstructured":"Celik, S., Yazici, Y., Sut, N. & Yazici, H. Pulmonary artery aneurysms in Beh\u00e7et\u2019s syndrome: a review of the literature with emphasis on geographical differences. Clin. Exp. Rheumatol. 33, S54\u2013S59 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR114","first-page":"S47","volume":"29","author":"H Ideguchi","year":"2011","unstructured":"Ideguchi, H. et al. Characteristics of vascular involvement in Beh\u00e7et\u2019s disease in Japan: a retrospective cohort study. Clin. Exp. Rheumatol. 29, S47\u2013S53 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR115","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3346\/jkms.2002.17.6.784","volume":"17","author":"HK Chang","year":"2002","unstructured":"Chang, H. K. & Kim, J. W. The clinical features of Behcet\u2019s disease in Yongdong districts: analysis of a cohort followed from 1997 to 2001. J. Korean Med. Sci. 17, 784\u2013789 (2002).","journal-title":"J. Korean Med. Sci."},{"key":"880_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-42","volume":"9","author":"L Savey","year":"2014","unstructured":"Savey, L. et al. Ethnicity and association with disease manifestations and mortality in Beh\u00e7et\u2019s disease. Orphanet J. Rare Dis. 9, 42 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"880_CR117","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/PAS.0b013e31814b23da","volume":"32","author":"I Lee","year":"2008","unstructured":"Lee, I. et al. Cardiac Beh\u00e7et disease presenting as aortic valvulitis\/aortitis or right heart inflammatory mass: a clinicopathologic study of 12 cases. Am. J. Surg. Pathol. 32, 390\u2013398 (2008).","journal-title":"Am. J. Surg. Pathol."},{"key":"880_CR118","first-page":"2393","volume":"29","author":"R Tunc","year":"2002","unstructured":"Tunc, R., Keyman, E., Melikoglu, M., Fresko, I. & Yazici, H. Target organ associations in Turkish patients with Beh\u00e7et\u2019s disease: a cross sectional study by exploratory factor analysis. J. Rheumatol. 29, 2393\u20132396 (2002).","journal-title":"J. Rheumatol."},{"key":"880_CR119","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/ard.2003.018515","volume":"63","author":"R Tunc","year":"2004","unstructured":"Tunc, R., Saip, S., Siva, A. & Yazici, H. Cerebral venous thrombosis is associated with major vessel disease in Beh\u00e7et\u2019s syndrome. Ann. Rheum. Dis. 63, 1693\u20131694 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR120","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/rheumatology\/ker423","volume":"51","author":"M Karaca","year":"2012","unstructured":"Karaca, M., Hatemi, G., Sut, N. & Yazici, H. The papulopustular lesion\/arthritis cluster of Beh\u00e7et\u2019s syndrome also clusters in families. Rheumatology 51, 1053\u20131060 (2012).","journal-title":"Rheumatology"},{"key":"880_CR121","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3906\/sag-1605-28","volume":"46","author":"H Yaz\u0131c\u0131","year":"2016","unstructured":"Yaz\u0131c\u0131, H. & Seyahi, E. Beh\u00e7et syndrome: the vascular cluster. Turk. J. Med. Sci. 46, 1277\u20131280 (2016).","journal-title":"Turk. J. Med. Sci."},{"key":"880_CR122","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.berh.2016.08.002","volume":"30","author":"E Seyahi","year":"2016","unstructured":"Seyahi, E. Beh\u00e7et\u2019s disease: how to diagnose and treat vascular involvement. Best. Pract. Res. Clin. Rheumatol. 30, 279\u2013295 (2016).","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"880_CR123","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2147\/JIR.S279912","volume":"14","author":"HF Hetta","year":"2021","unstructured":"Hetta, H. F. et al. Possible role of regulatory B cells in different Beh\u00e7et\u2019s disease phenotypes and therapies: first report from Egypt. J. Inflamm. Res. 14, 737\u2013744 (2021).","journal-title":"J. Inflamm. Res."},{"key":"880_CR124","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s10067-020-05536-z","volume":"40","author":"J Zou","year":"2021","unstructured":"Zou, J., Luo, D., Shen, Y. & Guan, J. L. Characteristics and phenotype heterogeneity in late-onset Beh\u00e7et\u2019s syndrome: a cohort from a referral center in China. Clin. Rheumatol. 40, 2319\u20132326 (2021).","journal-title":"Clin. Rheumatol."},{"key":"880_CR125","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.reuma.2020.04.007","volume":"17","author":"DHS Attia","year":"2021","unstructured":"Attia, D. H. S. Beh\u00e7et\u2019s disease phenotypes and clinical outcomes: a cohort study in Egyptian patients. Reumatol. Clin. 17, 514\u2013520 (2021).","journal-title":"Reumatol. Clin."},{"key":"880_CR126","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/art.24393","volume":"61","author":"D Saadoun","year":"2009","unstructured":"Saadoun, D. et al. Cerebral venous thrombosis in Beh\u00e7et\u2019s disease. Arthritis Rheum. 61, 518\u2013526 (2009).","journal-title":"Arthritis Rheum."},{"key":"880_CR127","doi-asserted-by":"crossref","first-page":"9518065","DOI":"10.1155\/2018\/9518065","volume":"2018","author":"MA Hussein","year":"2018","unstructured":"Hussein, M. A., Eissa, I. M. & Dahab, A. A. Vision-threatening Behcet\u2019s Disease: severity of ocular involvement predictors. J. Ophthalmol. 2018, 9518065 (2018).","journal-title":"J. Ophthalmol."},{"key":"880_CR128","doi-asserted-by":"publisher","DOI":"10.1177\/17085381211063038","author":"L Zou","year":"2021","unstructured":"Zou, L. et al. Long-term outcomes of endovascular treatment for aortic pseudoaneurysm in patients with Beh\u00e7et\u2019s disease. Vascular https:\/\/doi.org\/10.1177\/17085381211063038 (2021).","journal-title":"Vascular"},{"key":"880_CR129","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s11739-019-02040-4","volume":"14","author":"B Tutar","year":"2019","unstructured":"Tutar, B., Kantarci, F., Cakmak, O. S., Yazici, H. & Seyahi, E. Assessment of deep venous thrombosis in the lower extremity in Beh\u00e7et\u2019s syndrome: MR venography versus Doppler ultrasonography. Intern. Emerg. Med. 14, 705\u2013711 (2019).","journal-title":"Intern. Emerg. Med."},{"key":"880_CR130","first-page":"92","volume":"34","author":"SN Esatoglu","year":"2016","unstructured":"Esatoglu, S. N. et al. Bronchial artery enlargement may be the cause of recurrent haemoptysis in Beh\u00e7et\u2019s syndrome patients with pulmonary artery involvement during follow-up. Clin. Exp. Rheumatol. 34, 92\u201396 (2016).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR131","doi-asserted-by":"publisher","first-page":"9198506","DOI":"10.1155\/2019\/9198506","volume":"2019","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. The clinical features, risk factors, and outcome of aneurysmal lesions in Behcet\u2019s disease. J. Immunol. Res. 2019, 9198506 (2019).","journal-title":"J. Immunol. Res."},{"key":"880_CR132","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MD.0b013e318242ff37","volume":"91","author":"E Seyahi","year":"2012","unstructured":"Seyahi, E. et al. Pulmonary artery involvement and associated lung disease in Beh\u00e7et disease: a series of 47 patients. Medicine 91, 35\u201348 (2012).","journal-title":"Medicine"},{"key":"880_CR133","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.27568","volume":"62","author":"D Saadoun","year":"2010","unstructured":"Saadoun, D. et al. Mortality in Beh\u00e7et\u2019s disease. Arthritis Rheum. 62, 2806\u20132812 (2010).","journal-title":"Arthritis Rheum."},{"key":"880_CR134","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.semarthrit.2014.10.014","volume":"44","author":"E Seyahi","year":"2015","unstructured":"Seyahi, E. et al. An outcome survey of 43 patients with Budd-Chiari syndrome due to Beh\u00e7et\u2019s syndrome followed up at a single, dedicated center. Semin. Arthritis Rheum. 44, 602\u2013609 (2015).","journal-title":"Semin. Arthritis Rheum."},{"key":"880_CR135","doi-asserted-by":"publisher","first-page":"105277","DOI":"10.1016\/j.jbspin.2021.105277","volume":"89","author":"M Torgutalp","year":"2022","unstructured":"Torgutalp, M. et al. Analysis of vascular involvement in 460 patients with Beh\u00e7et\u2019s syndrome: clinical characteristics and associated factors. Jt. Bone Spine 89, 105277 (2022).","journal-title":"Jt. Bone Spine"},{"key":"880_CR136","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000494","volume":"94","author":"F Alibaz-Oner","year":"2015","unstructured":"Alibaz-Oner, F. et al. Beh\u00e7et disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses. Medicine 94, e494 (2015).","journal-title":"Medicine"},{"key":"880_CR137","first-page":"1491","volume":"40","author":"F Alibaz-Oner","year":"2022","unstructured":"Alibaz-Oner, F. et al. Vascular Beh\u00e7et\u2019s disease: a comparative study from Turkey and France. Clin. Exp. Rheumatol. 40, 1491\u20131496 (2022).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR138","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jvsv.2016.01.003","volume":"4","author":"F Alibaz-Oner","year":"2016","unstructured":"Alibaz-Oner, F. et al. Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Beh\u00e7et\u2019s disease. J. Vasc. Surg. Venous Lymphat. Disord. 4, 301\u2013306 (2016).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"880_CR139","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jvs.2015.02.060","volume":"62","author":"S Ugurlu","year":"2015","unstructured":"Ugurlu, S. et al. Venous claudication in Beh\u00e7et\u2019s disease. J. Vasc. Surg. 62, 698\u2013703.e691 (2015).","journal-title":"J. Vasc. Surg."},{"key":"880_CR140","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.jvsv.2021.02.007","volume":"9","author":"A Aksoy","year":"2021","unstructured":"Aksoy, A. et al. Predictors for the risk and severity of post-thrombotic syndrome in vascular Beh\u00e7et\u2019s disease. J. Vasc. Surg. Venous Lymphat. Disord. 9, 1451\u20131459 (2021).","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"880_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0153-1","volume":"9","author":"AC Desbois","year":"2014","unstructured":"Desbois, A. C. et al. Behcet\u2019s disease in Budd-Chiari syndrome. Orphanet J. Rare Dis. 9, 104 (2014).","journal-title":"Orphanet J. Rare Dis."},{"key":"880_CR142","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.clinre.2019.10.006","volume":"44","author":"MA Sakr","year":"2020","unstructured":"Sakr, M. A. et al. Characteristics and outcome of primary Budd-Chiari syndrome due to Beh\u00e7et\u2019s syndrome. Clin. Res. Hepatol. Gastroenterol. 44, 503\u2013512 (2020).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"880_CR143","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10067-021-05878-2","volume":"41","author":"L Akyol","year":"2022","unstructured":"Akyol, L. et al. Budd-Chiari syndrome in Beh\u00e7et\u2019s disease: a retrospective multicenter study. Clin. Rheumatol. 41, 177\u2013186 (2022).","journal-title":"Clin. Rheumatol."},{"key":"880_CR144","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1177\/2050640615582293","volume":"3","author":"P Martens","year":"2015","unstructured":"Martens, P. & Nevens, F. Budd-Chiari syndrome. United European Gastroenterol. J. 3, 489\u2013500 (2015).","journal-title":"United European Gastroenterol. J."},{"key":"880_CR145","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11739-018-1863-5","volume":"13","author":"GM Rossi","year":"2018","unstructured":"Rossi, G. M., Emmi, G. & Vaglio, A. Hemoptysis in Beh\u00e7et\u2019s syndrome: from bedside to bench? Intern. Emerg. Med. 13, 467\u2013469 (2018).","journal-title":"Intern. Emerg. Med."},{"key":"880_CR146","first-page":"132","volume":"37","author":"A Gokturk","year":"2019","unstructured":"Gokturk, A. et al. Increased frequency of obstructive sleep apnea syndrome in Beh\u00e7et\u2019s syndrome patients with superior vena cava syndrome. Clin. Exp. Rheumatol. 37, 132\u2013136 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR147","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1007\/s00415-009-5088-4","volume":"256","author":"N Yesilot","year":"2009","unstructured":"Yesilot, N. et al. Cerebral venous thrombosis in Beh\u00e7et\u2019s disease compared to those associated with other etiologies. J. Neurol. 256, 1134\u20131142 (2009).","journal-title":"J. Neurol."},{"key":"880_CR148","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1093\/rheumatology\/key153","volume":"58","author":"D Uluduz","year":"2019","unstructured":"Uluduz, D. et al. Beh\u00e7et\u2019s disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study. Rheumatology 58, 600\u2013608 (2019).","journal-title":"Rheumatology"},{"key":"880_CR149","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1212\/WNL.0b013e318238edeb","volume":"77","author":"D Uluduz","year":"2011","unstructured":"Uluduz, D. et al. Clinical characteristics of pediatric-onset neuro-Beh\u00e7et disease. Neurology 77, 1900\u20131905 (2011).","journal-title":"Neurology"},{"key":"880_CR150","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.020","volume":"26","author":"T Duman","year":"2017","unstructured":"Duman, T. et al. A multicenter study of 1144 patients with cerebral venous thrombosis: the VENOST study. J. Stroke Cerebrovasc. Dis. 26, 1848\u20131857 (2017).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"880_CR151","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/rheumatology\/key279","volume":"58","author":"D Prisco","year":"2019","unstructured":"Prisco, D., Silvestri, E., Di Scala, G. & Emmi, G. Beh\u00e7et\u2019s disease as a cause of cerebral sinus vein thrombosis: an emerging role. Rheumatology 58, 563\u2013564 (2019).","journal-title":"Rheumatology"},{"key":"880_CR152","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00415-010-5885-9","volume":"258","author":"D Aguiar de Sousa","year":"2011","unstructured":"Aguiar de Sousa, D., Mestre, T. & Ferro, J. M. Cerebral venous thrombosis in Beh\u00e7et\u2019s disease: a systematic review. J. Neurol. 258, 719\u2013727 (2011).","journal-title":"J. Neurol."},{"key":"880_CR153","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.rmed.2011.07.022","volume":"105","author":"E Seyahi","year":"2011","unstructured":"Seyahi, E. et al. The estimated pulmonary artery pressure can be elevated in Beh\u00e7et\u2019s syndrome. Respir. Med. 105, 1739\u20131747 (2011).","journal-title":"Respir. Med."},{"key":"880_CR154","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1055\/s-0037-1604411","volume":"66","author":"\u015e Y\u0131ld\u0131zeli","year":"2018","unstructured":"Y\u0131ld\u0131zeli, \u015e. et al. Outcomes of patients with Beh\u00e7et\u2019s syndrome after pulmonary endarterectomy. Thorac. Cardiovasc. Surg. 66, 187\u2013192 (2018).","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"880_CR155","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1053\/j.semtcvs.2018.07.008","volume":"30","author":"H Tuzun","year":"2018","unstructured":"Tuzun, H. et al. Surgical treatment of pulmonary complications in Beh\u00e7et\u2019s syndrome. Semin. Thorac. Cardiovasc. Surg. 30, 369\u2013378 (2018).","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"880_CR156","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.amjmed.2004.05.027","volume":"117","author":"V Hamuryudan","year":"2004","unstructured":"Hamuryudan, V. et al. Pulmonary artery aneurysms in Beh\u00e7et syndrome. Am. J. Med. 117, 867\u2013870 (2004).","journal-title":"Am. J. Med."},{"key":"880_CR157","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MD.0b013e3182428126","volume":"91","author":"D Saadoun","year":"2012","unstructured":"Saadoun, D. et al. Long-term outcome of arterial lesions in Beh\u00e7et disease: a series of 101 patients. Medicine 91, 18\u201324 (2012).","journal-title":"Medicine"},{"key":"880_CR158","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e3182428f49","volume":"91","author":"G Geri","year":"2012","unstructured":"Geri, G. et al. Spectrum of cardiac lesions in Beh\u00e7et disease: a series of 52 patients and review of the literature. Medicine 91, 25\u201334 (2012).","journal-title":"Medicine"},{"key":"880_CR159","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1378\/chest.118.2.479","volume":"118","author":"N Mogulkoc","year":"2000","unstructured":"Mogulkoc, N., Burgess, M. I. & Bishop, P. W. Intracardiac thrombus in Beh\u00e7et\u2019s disease: a systematic review. Chest 118, 479\u2013487 (2000).","journal-title":"Chest"},{"key":"880_CR160","first-page":"S87","volume":"32","author":"H Emmungil","year":"2014","unstructured":"Emmungil, H. et al. A rare but serious manifestation of Beh\u00e7et\u2019s disease: intracardiac thrombus in 22 patients. Clin. Exp. Rheumatol. 32, S87\u2013S92 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR161","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10067-013-2205-7","volume":"32","author":"Y Fei","year":"2013","unstructured":"Fei, Y. et al. Major vascular involvement in Beh\u00e7et\u2019s disease: a retrospective study of 796 patients. Clin. Rheumatol. 32, 845\u2013852 (2013).","journal-title":"Clin. Rheumatol."},{"key":"880_CR162","doi-asserted-by":"publisher","first-page":"749","DOI":"10.21470\/1678-9741-2019-0003","volume":"34","author":"U Vural","year":"2019","unstructured":"Vural, U., Kizilay, M. & Aglar, A. A. Coronary involvement in Beh\u00e7et\u2019s disease: what are its risks and prognosis? (Rare cases and literature review). Braz. J. Cardiovasc. Surg. 34, 749\u2013758 (2019).","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"880_CR163","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2214\/ajr.164.1.7998568","volume":"164","author":"A Tunaci","year":"1995","unstructured":"Tunaci, A., Berkmen, Y. M. & G\u00f6kmen, E. Thoracic involvement in Beh\u00e7et\u2019s disease: pathologic, clinical, and imaging features. AJR Am. J. Roentgenol. 164, 51\u201356 (1995).","journal-title":"AJR Am. J. Roentgenol."},{"key":"880_CR164","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.diii.2014.10.006","volume":"95","author":"F Bonneville","year":"2014","unstructured":"Bonneville, F. Imaging of cerebral venous thrombosis. Diagn. Interv. Imaging 95, 1145\u20131150 (2014).","journal-title":"Diagn. Interv. Imaging"},{"key":"880_CR165","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/bjs.1800811205","volume":"81","author":"AW Bradbury","year":"1994","unstructured":"Bradbury, A. W., Milne, A. A. & Murie, J. A. Surgical aspects of Beh\u00e7et\u2019s disease. Br. J. Surg. 81, 1712\u20131721 (1994).","journal-title":"Br. J. Surg."},{"key":"880_CR166","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejrad.2017.11.012","volume":"98","author":"G Mehdipoor","year":"2018","unstructured":"Mehdipoor, G., Davatchi, F., Ghoreishian, H. & Arjmand Shabestari, A. Imaging manifestations of Behcet\u2019s disease: key considerations and major features. Eur. J. Radiol. 98, 214\u2013225 (2018).","journal-title":"Eur. J. Radiol."},{"key":"880_CR167","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/thorax.56.7.572","volume":"56","author":"F Erkan","year":"2001","unstructured":"Erkan, F., G\u00fcl, A. & Tasali, E. Pulmonary manifestations of Beh\u00e7et\u2019s disease. Thorax 56, 572\u2013578 (2001).","journal-title":"Thorax"},{"key":"880_CR168","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.semarthrit.2010.05.006","volume":"40","author":"SB Cho","year":"2011","unstructured":"Cho, S. B. et al. Detection of cardiovascular system involvement in Beh\u00e7et\u2019s disease using fluorodeoxyglucose positron emission tomography. Semin. Arthritis Rheum. 40, 461\u2013466 (2011).","journal-title":"Semin. Arthritis Rheum."},{"key":"880_CR169","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jbspin.2012.11.003","volume":"80","author":"S Trad","year":"2013","unstructured":"Trad, S. et al. 18F-fluorodeoxyglucose-positron emission tomography scanning is a useful tool for therapy evaluation of arterial aneurysm in Beh\u00e7et\u2019s disease. Jt. Bone Spine 80, 420\u2013423 (2013).","journal-title":"Jt. Bone Spine"},{"key":"880_CR170","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1007\/s00259-019-04365-w","volume":"46","author":"XY Xi","year":"2019","unstructured":"Xi, X. Y. et al. Multiple cardiovascular involvements in Beh\u00e7et\u2019s disease: unique utility of 18F-FDG PET\/CT in diagnosis and follow-up. Eur. J. Nucl. Med. Mol. Imaging 46, 2210\u20132211 (2019).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"880_CR171","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0967-2109(95)00027-5","volume":"4","author":"A Kuzu","year":"1996","unstructured":"Kuzu, A., K\u00f6ksoy, C., Ozaslan, C., G\u00fcrler, A. & T\u00fcz\u00fcner, A. Evaluation of peripheral vascular system disorders in vascular symptom-free Beh\u00e7et\u2019s disease. Cardiovasc. Surg. 4, 381\u2013383 (1996).","journal-title":"Cardiovasc. Surg."},{"key":"880_CR172","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00296-010-1603-2","volume":"32","author":"B Kisacik","year":"2012","unstructured":"Kisacik, B. et al. Investigation of the veins in patients with Beh\u00e7et\u2019s disease with no known vascular event by Doppler ultrasonography. Rheumatol. Int. 32, 303\u2013306 (2012).","journal-title":"Rheumatol. Int."},{"key":"880_CR173","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10067-013-2382-4","volume":"33","author":"F Alibaz-Oner","year":"2014","unstructured":"Alibaz-Oner, F., Karatay, E., Akpinar, I. N., Ergun, T. & Direskeneli, H. Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet\u2019s disease without overt thrombosis. Clin. Rheumatol. 33, 277\u2013280 (2014).","journal-title":"Clin. Rheumatol."},{"key":"880_CR174","first-page":"S99","volume":"32","author":"N Ambrose","year":"2014","unstructured":"Ambrose, N., Pierce, I. T., Gatehouse, P. D., Haskard, D. O. & Firmin, D. N. Magnetic resonance imaging of vein wall thickness in patients with Beh\u00e7et\u2019s syndrome. Clin. Exp. Rheumatol. 32, S99\u2013S102 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"880_CR175","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s10067-019-04470-z","volume":"38","author":"F Alibaz-Oner","year":"2019","unstructured":"Alibaz-Oner, F. et al. Venous vessel wall thickness in lower extremity is increased in male patients with Behcet\u2019s disease. Clin. Rheumatol. 38, 1447\u20131451 (2019). This is the first controlled Doppler ultrasonography study showing increased venous vessel wall thickness of lower-extremity veins in male patients with Beh\u00e7et syndrome compared with male healthy controls or male patients affected by ankylosing spondylitis.","journal-title":"Clin. Rheumatol."},{"key":"880_CR176","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jvsv.2018.11.006","volume":"7","author":"E Seyahi","year":"2019","unstructured":"Seyahi, E. et al. Increased vein wall thickness in Beh\u00e7et disease. J. Vasc. Surg. Venous Lymphat. Disord. 7, 677\u2013684.e672 (2019). This study showed an increased vein wall thickness of proximal deep and superficial lower-extremity veins in patients with Beh\u00e7et syndrome without any clinical and radiological vascular involvement.","journal-title":"J. Vasc. Surg. Venous Lymphat. Disord."},{"key":"880_CR177","doi-asserted-by":"publisher","first-page":"258","DOI":"10.46497\/ArchRheumatol.2021.8423","volume":"36","author":"S Kaymaz","year":"2021","unstructured":"Kaymaz, S. et al. Ultrasonographic measurement of the vascular wall thickness and intima-media thickness in patients with Beh\u00e7et\u2019s disease with symptoms or signs of vascular involvement: a cross-sectional study. Arch. Rheumatol. 36, 258\u2013266 (2021).","journal-title":"Arch. Rheumatol."},{"key":"880_CR178","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1097\/RHU.0000000000001788","volume":"28","author":"D Tezcan","year":"2022","unstructured":"Tezcan, D. et al. Diagnostic performance of lower extremity venous wall thickness and laboratory findings in the diagnosis of the Beh\u00e7et disease. J. Clin. Rheumatol. 28, e521\u2013e527 (2022).","journal-title":"J. Clin. Rheumatol."},{"key":"880_CR179","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac452","author":"SK Agackiran","year":"2022","unstructured":"Agackiran, S. K. et al. Pulmonary arterial wall thickness is increased in Beh\u00e7et\u2019s disease patients with major organ involvement: is it a sign of severity? Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/keac452 (2022).","journal-title":"Rheumatology"},{"key":"880_CR180","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/rheumatology\/keaa264","volume":"60","author":"F Alibaz-Oner","year":"2021","unstructured":"Alibaz-Oner, F. et al. Femoral vein wall thickness measurement: a new diagnostic tool for Beh\u00e7et\u2019s disease. Rheumatology 60, 288\u2013296 (2021).","journal-title":"Rheumatology"},{"key":"880_CR181","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1007\/s10620-020-06587-7","volume":"66","author":"F Alibaz-Oner","year":"2021","unstructured":"Alibaz-Oner, F. et al. Femoral vein wall thickness measurement may be a distinctive diagnostic tool to differentiate Beh\u00e7et\u2019s disease with intestinal involvement and Crohn\u2019s Disease. Dig. Dis. Sci. 66, 2750\u20132755 (2021).","journal-title":"Dig. Dis. Sci."},{"key":"880_CR182","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41927-020-00172-1","volume":"5","author":"M Kiafar","year":"2021","unstructured":"Kiafar, M. et al. Diagnosis of Beh\u00e7et\u2019s disease: clinical characteristics, diagnostic criteria, and differential diagnoses. BMC Rheumatol. 5, 2 (2021).","journal-title":"BMC Rheumatol."},{"key":"880_CR183","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac314","author":"E Atalay","year":"2022","unstructured":"Atalay, E. et al. A new tool supporting the diagnosis of childhood-onset Beh\u00e7et\u2019s disease: venous wall thickness. Rheumatology https:\/\/doi.org\/10.1093\/rheumatology\/keac314 (2022).","journal-title":"Rheumatology"},{"key":"880_CR184","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","volume":"43","author":"G Lawton","year":"2004","unstructured":"Lawton, G., Bhakta, B. B., Chamberlain, M. A. & Tennant, A. The Beh\u00e7et\u2019s disease activity index. Rheumatology 43, 73\u201378 (2004).","journal-title":"Rheumatology"},{"key":"880_CR185","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.23225","volume":"58","author":"Swearingen,C Forbess C","year":"2008","unstructured":"Forbess C, Swearingen, C. & Yazici, Y. Beh\u00e7et\u2019s syndrome activity score (BSAS): a new disease activity assessment tool, composed of patient-derived measures only, is strongly correlated with the Beh\u00e7et\u2019s disease current activity form (BDCAF). Arthritis Rheum. 58, 854 (2008).","journal-title":"Arthritis Rheum."},{"key":"880_CR186","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","volume":"29","author":"KE Sharquie","year":"2002","unstructured":"Sharquie, K. E., Najim, R. A. & Abu-Raghif, A. R. Dapsone in Beh\u00e7et\u2019s disease: a double-blind, placebo-controlled, cross-over study. J. Dermatol. 29, 267\u2013279 (2002).","journal-title":"J. Dermatol."},{"key":"880_CR187","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3109\/s10165-009-0191-z","volume":"19","author":"F Shahram","year":"2009","unstructured":"Shahram, F. et al. Comparison of existing disease activity indices in the follow-up of patients with Beh\u00e7et\u2019s disease. Mod. Rheumatol. 19, 536\u2013541 (2009).","journal-title":"Mod. Rheumatol."},{"key":"880_CR188","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3899\/jrheum.141147","volume":"42","author":"G Hatemi","year":"2015","unstructured":"Hatemi, G. et al. Current status, goals, and research agenda for outcome measures development in Beh\u00e7et syndrome: report from OMERACT 2014. J. Rheumatol. 42, 2436\u20132441 (2015).","journal-title":"J. Rheumatol."},{"key":"880_CR189","first-page":"931","volume":"31","author":"G Gilworth","year":"2004","unstructured":"Gilworth, G. et al. Development of the BD-QoL: a quality of life measure specific to Beh\u00e7et\u2019s disease. J. Rheumatol. 31, 931\u2013937 (2004).","journal-title":"J. Rheumatol."},{"key":"880_CR190","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1538-7836.2009.03294.x","volume":"7","author":"SR Kahn","year":"2009","unstructured":"Kahn, S. R., Partsch, H., Vedantham, S., Prandoni, P. & Kearon, C. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J. Thromb. Haemost. 7, 879\u2013883 (2009).","journal-title":"J. Thromb. Haemost."},{"key":"880_CR191","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/acr.24511","volume":"74","author":"G Hatemi","year":"2022","unstructured":"Hatemi, G. et al. Core set of domains for outcome measures in Beh\u00e7et\u2019s syndrome. Arthritis Care Res. 74, 691\u2013699 (2022).","journal-title":"Arthritis Care Res."},{"key":"880_CR192","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/rheumatology\/kel382","volume":"46","author":"N Sut","year":"2007","unstructured":"Sut, N., Seyahi, E., Yurdakul, S., Senocak, M. & Yazici, H. A cost analysis of Beh\u00e7et\u2019s syndrome in Turkey. Rheumatology 46, 678\u2013682 (2007).","journal-title":"Rheumatology"},{"key":"880_CR193","first-page":"808","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi, G. et al. 2018 update of the EULAR recommendations for the management of Behcet\u2019s syndrome. Ann. Rheum. Dis. 77, 808\u2013818 (2018). EULAR recommendations for the treatment of Beh\u00e7et syndrome.","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR194","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/rheumatology\/key242","volume":"57","author":"Y Ozguler","year":"2018","unstructured":"Ozguler, Y. et al. Management of major organ involvement of Beh\u00e7et\u2019s syndrome: a systematic review for update of the EULAR recommendations. Rheumatology 57, 2200\u20132212 (2018).","journal-title":"Rheumatology"},{"key":"880_CR195","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/art.40531","volume":"70","author":"G Emmi","year":"2018","unstructured":"Emmi, G. et al. Adalimumab-based treatment versus disease-modifying antirheumatic drugs for venous thrombosis in Beh\u00e7et\u2019s syndrome: a retrospective study of seventy patients with vascular involvement. Arthritis Rheumatol. 70, 1500\u20131507 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"880_CR196","doi-asserted-by":"publisher","first-page":"624795","DOI":"10.3389\/fmed.2021.624795","volume":"8","author":"E Alpsoy","year":"2021","unstructured":"Alpsoy, E., Leccese, P., Emmi, G. & Ohno, S. Treatment of Beh\u00e7et\u2019s disease: an algorithmic multidisciplinary approach. Front. Med. 8, 624795 (2021).","journal-title":"Front. Med."},{"key":"880_CR197","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/1756-185X.13778","volume":"23","author":"A Aksoy","year":"2020","unstructured":"Aksoy, A. et al. Efficacy of TNF\u03b1 inhibitors for refractory vascular Beh\u00e7et\u2019s disease: a multicenter observational study of 27 patients and a review of the literature. Int. J. Rheum. Dis. 23, 256\u2013261 (2020).","journal-title":"Int. J. Rheum. Dis."},{"key":"880_CR198","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","volume":"27","author":"JK Ahn","year":"2008","unstructured":"Ahn, J. K., Lee, Y. S., Jeon, C. H., Koh, E. M. & Cha, H. S. Treatment of venous thrombosis associated with Behcet\u2019s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin. Rheumatol. 27, 201\u2013205 (2008). This retrospective study suggests that immunosuppressive therapy is essential for the treatment of deep venous thrombosis associated with Beh\u00e7et syndrome.","journal-title":"Clin. Rheumatol."},{"key":"880_CR199","doi-asserted-by":"publisher","first-page":"102783","DOI":"10.1016\/j.autrev.2021.102783","volume":"20","author":"M Vautier","year":"2021","unstructured":"Vautier, M. et al. Direct oral anticoagulant for venous thrombosis in Beh\u00e7et\u2019s syndrome. Autoimmun. Rev. 20, 102783 (2021). This is an observational study on the role of anticoagulation for the treatment of vascular thrombosis in Beh\u00e7et syndrome.","journal-title":"Autoimmun. Rev."},{"key":"880_CR200","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5152\/akd.2014.5042","volume":"14","author":"A Hamzaoui","year":"2014","unstructured":"Hamzaoui, A. et al. Vena cava thrombosis in Beh\u00e7et\u2019s disease. Anadolu Kardiyol. Derg. 14, 292\u2013293 (2014).","journal-title":"Anadolu Kardiyol. Derg."},{"key":"880_CR201","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s12328-020-01106-7","volume":"13","author":"CM Oblitas","year":"2020","unstructured":"Oblitas, C. M. et al. Chronic Budd-Chiari syndrome in Beh\u00e7et\u2019s disease successfully managed with transjugular intrahepatic portosystemic shunt: a case report and literature review. Clin. J. Gastroenterol. 13, 572\u2013578 (2020).","journal-title":"Clin. J. Gastroenterol."},{"key":"880_CR202","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10067-017-3718-2","volume":"37","author":"J Shi","year":"2018","unstructured":"Shi, J. et al. Cerebral venous sinus thrombosis in Beh\u00e7et\u2019s disease: a retrospective case-control study. Clin. Rheumatol. 37, 51\u201357 (2018).","journal-title":"Clin. Rheumatol."},{"key":"880_CR203","first-page":"2103","volume":"22","author":"D Le Thi Huong","year":"1995","unstructured":"Le Thi Huong, D. et al. Arterial lesions in Beh\u00e7et\u2019s disease. A study in 25 patients. J. Rheumatol. 22, 2103\u20132113 (1995).","journal-title":"J. Rheumatol."},{"key":"880_CR204","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/rheumatology\/33.1.48","volume":"33","author":"V Hamuryudan","year":"1994","unstructured":"Hamuryudan, V. et al. Pulmonary arterial aneurysms in Beh\u00e7et\u2019s syndrome: a report of 24 cases. Br. J. Rheumatol. 33, 48\u201351 (1994).","journal-title":"Br. J. Rheumatol."},{"key":"880_CR205","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1024\/0301-1526.32.2.75","volume":"32","author":"D Saba","year":"2003","unstructured":"Saba, D. et al. Arterial lesions in Beh\u00e7et\u2019s disease. Vasa 32, 75\u201381 (2003).","journal-title":"Vasa"},{"key":"880_CR206","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2018.08.004","volume":"197","author":"AC Desbois","year":"2018","unstructured":"Desbois, A. C. et al. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet\u2019s disease: a multicenter observational study of 18 patients. Clin. Immunol. 197, 54\u201359 (2018).","journal-title":"Clin. Immunol."},{"key":"880_CR207","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.semarthrit.2015.06.008","volume":"45","author":"V Hamuryudan","year":"2015","unstructured":"Hamuryudan, V. et al. Pulmonary artery involvement in Beh\u00e7ets syndrome: effects of anti-Tnf treatment. Semin. Arthritis Rheum. 45, 369\u2013373 (2015).","journal-title":"Semin. Arthritis Rheum."},{"key":"880_CR208","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.autrev.2016.01.003","volume":"15","author":"E Chan","year":"2016","unstructured":"Chan, E., Sangle, S. R., Coghlan, J. G. & D\u2019Cruz, D. D. Pulmonary artery aneurysms in Beh\u00e7et\u2019s disease treated with anti-TNF\u03b1: a case series and review of the literature. Autoimmun. Rev. 15, 375\u2013378 (2016).","journal-title":"Autoimmun. Rev."},{"key":"880_CR209","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00296-013-2700-9","volume":"33","author":"SS Yang","year":"2013","unstructured":"Yang, S. S. et al. Peripheral arterial involvement in Behcet\u2019s disease: an analysis of the results from a Korean referral center. Rheumatol. Int. 33, 2101\u20132108 (2013).","journal-title":"Rheumatol. Int."},{"key":"880_CR210","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ejvs.2011.05.010","volume":"42","author":"C Koksoy","year":"2011","unstructured":"Koksoy, C. et al. Surgical treatment of peripheral aneurysms in patients with Behcet\u2019s disease. Eur. J. Vasc. Endovasc. Surg. 42, 525\u2013530 (2011).","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"880_CR211","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/rheumatology\/keab840","volume":"61","author":"H Zhong","year":"2022","unstructured":"Zhong, H. et al. Efficacy and safety of tocilizumab in Beh\u00e7et\u2019s syndrome with refractory arterial lesions: a single-centre observational cohort study in China. Rheumatology 61, 2923\u20132930 (2022).","journal-title":"Rheumatology"},{"key":"880_CR212","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/annrheumdis-2020-217307","volume":"79","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. A pilot study of tofacitinib for refractory Beh\u00e7et\u2019s syndrome. Ann. Rheum. Dis. 79, 1517\u20131520 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"880_CR213","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.avsg.2020.05.072","volume":"69","author":"SW Chung","year":"2020","unstructured":"Chung, S. W. et al. Surgical experience of Behcet\u2019s disease involving the peripheral artery. Ann. Vasc. Surg. 69, 246\u2013253 (2020).","journal-title":"Ann. Vasc. Surg."},{"key":"880_CR214","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.jvs.2020.01.076","volume":"72","author":"J Gaudric","year":"2020","unstructured":"Gaudric, J. et al. Factors influencing the recurrence of arterial involvement after surgical repair in Beh\u00e7et disease. J. Vasc. Surg. 72, 1761\u20131769 (2020).","journal-title":"J. Vasc. Surg."},{"key":"880_CR215","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s10067-006-0530-9","volume":"26","author":"MC Park","year":"2007","unstructured":"Park, M. C., Hong, B. K., Kwon, H. M. & Hong, Y. S. Surgical outcomes and risk factors for postoperative complications in patients with Behcet\u2019s disease. Clin. Rheumatol. 26, 1475\u20131480 (2007).","journal-title":"Clin. Rheumatol."},{"key":"880_CR216","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0039-6060(97)90284-1","volume":"121","author":"H T\u00fcz\u00fcn","year":"1997","unstructured":"T\u00fcz\u00fcn, H. et al. Management of aneurysms in Beh\u00e7et\u2019s syndrome: an analysis of 24 patients. Surgery 121, 150\u2013156 (1997).","journal-title":"Surgery"},{"key":"880_CR217","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s42358-021-00193-5","volume":"61","author":"FT Elgengehy","year":"2021","unstructured":"Elgengehy, F. T. et al. Vasculitis damage index in Beh\u00e7et\u2019s disease. Adv. Rheumatol. 61, 33 (2021).","journal-title":"Adv. Rheumatol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00880-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00880-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00880-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T09:07:39Z","timestamp":1674810459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-022-00880-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":217,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1038\/s41584-022-00880-7","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"21 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.A.-O. has received honoraria, consulting or speaker fees from Pfizer, AbbVie and Amgen. H.D. has received honoraria, consulting and speaker fees from AbbVie, Pfizer, Roche, Novartis, UCB Pharma, Amgen and Celltrione. G.E. has received honoraria and speaker fees from Novartis, Roche, Sobi, AstraZeneca, Boehringer Ingelheim, Janssen, Sanofi and GSK. G.H. has received research grants, honoraria and speaker fees from AbbVie, Amgen, Boehringer Ingelheim, Celgene, Celltrion, Janssen, Novartis, Pfizer, Silk Road Therapeutics and UCB Pharma. D.S. has received honoraria, consulting or speaker fees from Novartis, Amgen, Celltrion, Celgene, Roche Chugai, Viatris, Sanofi and AbbVie. E.S. has received honoraria, consulting or speaker fees from Novartis, Pfizer and AbbVie. A.B. and D.P. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}